Assessment of Interleukin-1β in Saliva of Smoker and Non-smoker Patients with Chronic Periodontitis.
Keywords:Chronic periodontitis, Saliva, Interleukin-1β, Smoking
Background and objectives: Smoking is considered a significant risk factor in periodontitis. The pathogenesis of periodontal disease may be affected by alterations of the inflammatory response by smoke. Interleukin-1 (IL-1β), an effective pro-inflammatory cytokine have been associated with the immunopathology of periodontitis. The aim of this study was to assess the levels of IL-1β in saliva from smokers and non-smokers with chronic periodontitis and periodontally healthy controls.
Materials and methods: Gingival index, Plaque index, probing pocket depth, clinical attachment level, bleeding on probing were assessed in 84 subjects who were equally divided in to three groups. group I periodontally healthy non-smoking subjects ; group II non-smokers with chronic periodontitis; group III smokers with chronic periodontitis; Enzyme Linked Immunosorbent Assay (ELISA) test was used for quantification of Interleukin (IL)- 1β in the saliva samples. Statistical analysis were performed with SPSS version 22.0.
Results: Interleukin-1β level in saliva was significantly higher in smoker than in nonsmokers with chronic periodontitis and the controls (P˂ 0.001). In subjects with chronic periodontitis, a significant correlation existed between CAL and IL-β (r= 0.313, p= 0.052) among non-smokers; there was also a highly significant positive correlation between, CAL and IL-β (r= 0.310, p= 0.051), BOP and IL-β (r= 0.333, p= 0.05) among smokers.
Conclusion: Salivary IL-1β level were significantly elevated in periodontitis patients. Smokers with chronic periodontitis exhibited a highly significant increase in salivary IL-1β levels. Hence, this reflects the impact of smoking on immune response and its role in the pathogenesis of periodontal disease.
Savage A, Eaton KA, Moles DR, Needleman I. A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J Clin periodontol. 2009;36(6):458-67. doi: 10.1111/j.1600-051X.2009.01408.x
Satpathy A, Ravindra S, Thakur S, Kulkarni S, Porwal A, Panda S. Serum interleukin-1β in subjects with abdominal obesity and periodontitis. Obes Res Clin Pract. 2015 1;9(5):513-21. doi: 10.1016/j.orcp.2015.01.005. Epub 2015 Feb 11.
Banjar W, Alshammari MH (2014) Genetic factors in pathogenesis of chronic periodontitis. J Taibah Univ Sci 9: 245-247. doi: 10.1155/2017/1914073
Khademi B, Hashemi SB, Ghaderi A, Shahrestani A, Mohammadianpanah M. Interleukin-13 gene polymorphisms at-1055 C/T and+ 2044 G/A positions in patients with squamous cell carcinoma of head and neck. Braz j otorhinolaryngol. 2012;78(5):64-8.
Könönen E, Kumar PS. Bacteriology of periodontal diseases. In Molecular Medical Microbiology 2015 (pp. 957-968). Academic Press.
Deo V and Bhongade ML. "Pathogenesis of periodontitis: role of cytokines in host response". Dent. Today 2010; 29(9):60-2.
Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000. 1997;14(1):33-53. DOI:10.1111/j.1600-0757.1997.tb00191.x
Kurşunlu SF, Özturk VO, Han B, Atmaca H, Emingil G. Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease. Arch Oral Biol 2015; 60: 77-83. Doi: 10.1016/j.archoralbio.2014.08.021.
Grover HS, Kapoor S, Singh A. Effect of topical simvastatin (1.2mg) on gingival crevicular fluid interleukin-6, Interleukin-8 and Interleukin-10 levels in chronic periodontitis. A clinicobiochemical study. J Oral Biol Craniofac Res 2016; 6:85-92. doi: 10.4103/ccd.ccd_848_16
Christopher G Rosenvall .Trauma and Cytokines: Gingival Crevicular Fluid Biomarkers in Traumatized Permanent Incisors. A master thesis. The Ohio State University.2013.
Souto GR, Queiroz-Junior CM, Costa FO, Mesquita RA. Effect of smoking on immunity in human chronic periodontitis. Immunobiology. 2014 Dec 1;219(12):909-15. doi: 10.1016/j.imbio.2014.08.003.
Ben-Sasson SZ, Hu-Li J, Quiel J, et al. IL-1 acts directly on CD4 T cells to enhance their antigendriven expansion and differentiation. Proc Natl Acad Sci USA 2009;106(17):7119-24.
Faizuddin M, Bharathi SH, Rohini NV. Estimation of interleukin‐1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. Journal of periodontal research. 2003; 38(2):111-4.
Bloemen V, Schoenmaker T, de Vries TJ, Everts V. IL‐1β favors osteoclastogenesis via supporting human periodontal ligament fibroblasts. J cell biochem. 2011; 112(7): 1890-7.
Ojima M and Hanioka T.. (2010). Destructive effects of smoking on molecular and genetic factors of periodontal disease. Tob Indu Dis, 8:4.
Ryder MI. The influence of smoking on host responses in periodontal infections. Periodontol 2000 2007;43;267-77
Martinez-Canut P, Lorca A, Magán R. Smoking and periodontal disease severity. J Clin Periodontol 1995; 22(10): 743-9. [http://dx.doi.org/10.1111/j.1600-051X.1995.tb00256.x] [PMID: 8682920]
Albandar JM, Streckfus CF, Adesanya MR, Winn DM. Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 2000;71:1874-81.
Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.
Tymkiw KD, Thunell DH, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, et al. Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. J Clin Periodontol 2011;38:219-28.
Navazesh M. Methods for collection saliva. Ann N Y Acad Sci 1993; 694:727.
Mullary BH. The influence of tobacco smoking on the onset of periodontitis in young persons. Tpb Induc Dis 2004; 2(2):53-65.
Johnson GK, Guthmiller JM, Joly S, Organ CC, Dawson DV: Interleukin-1 and Interleukin-8 in nicotine and lipopolysaccharide-exposed gingival keratinocyte cultures. J Periodontal Res 2010;45:583-88.
Al-Ghurabi BH. Impact of Smoking on the IL-1 [Beta], IL-8, IL-10, IL-17 and TNF-α Production in Chronic Periodontitis Patients. J Asian Sci Res. 2013; 3(5):462-70.
Jenifer HD, Bhola S, Kalburgi V, Warad S, Kokatnur VM. The influence of cigarette smoking on blood and salivary super oxide dismutase enzyme levels among smokers and nonsmokers—A cross sectional study. J Tradi Complement Medicine. 2015 1;5(2):100-5.
Novak MJ, Novak KF. Smoking and periodontal disease. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, eds. Carranza's Clinical Periodontology. 9th ed. Philadelphia, PA: Saunders; 2003:245e252.
Scabbia A, Cho KS, Sigurdsson TJ, Kim CK, Trombelli L. Cigarette smoking negatively affects healing response following flap debridement surgery. J Periodontol . 2001;72(1):43-9.
Gaphor SM, Ali SH, Abdullah MJ. Evaluation of salivary interleukin-1 beta (IL-1β) level in relation to the periodontal status in smoker and nonsmoker individuals. J Interdiscipl Med Den Sci ; 2(3): 1-5.
Calsina G, Ramón JM, Echeverría JJ. Effects of smoking on periodontal tissues. J Clin Periodontol. 2002;29(8):771-6.
Patel RP , Amirisetty R, Kalakonda B, Penumatsa NV, Koppolu P. Influence of Smoking on Gingival Crevicular Fluid Interleukin- 1β and Interleukin-8 in Patients with Severe Chronic Periodontitis among a Rural Population in India. Niger Med J. 2018 ; 59(4): 33–38
Machuca G, Rosales I, Lacalle JR, Machuca C, Bullón P. Effect of cigarette smoking on periodontal status of healthy young adults. J Periodontol 2000;71(1):73-8.
Newman MG, Takei HH, Carranza FA: Carranzaʼs Clinical Periodontology, 9th edition, St. Louis, Missouri: Saunders Elsevier. 2002.
Gautam DK, Jindal V, Gupta SC, Tuli A, Kotwal B, Thakur R. Effect of cigarette smoking on the periodontal health status: A comparative, cross sectional study. J Indian Soc Periodontol. 2011 ;15(4):383-87.
Yucel-Lindberg T, Nilsson S, Modeer T. Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1β and tumor necrosis factor a in human gingival fibroblasts. J Dental Res. 1999;78(1):61-8.
Yoshinari N, Kawase H, Mitani A, Ito M, Sugiishi S, Matsuoka M. Effect of scaling and root planning on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1 beta in gingival crevicular fluid and gingival tissues. J Periodontal Res 2004; 39: 158-67.
Tambwekar KR, Kakariya RB, Garg S. A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations. J Pharm Biomed Anal 2003; 32:441-50.
Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non‐smokers. J Clin periodontol. 2003;30(1):42-8.
Moeintaghavi A, Arab HR, Rezaee SA, Naderi H, Shiezadeh F, Sadeghi S, Anvari N. The effects of smoking on expression of IL-12 and IL-1β in gingival tissues of patients with chronic periodontitis. Open Dent j 2017;11:595-602. doi: 10.2174/1874210601711010595
Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J AmDent Assoc 2006;137:322-29.
How to Cite
Copyright (c) 2021 Solav Abdul-Qadir Mustafa, Haween T. Nanakaly, Hozan Wrya Azeez (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Erbil Dental Journal is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).